Swiss companies have been approved human pooled plasma from FDA = (BW)

Octapharma Plasma leading Swiss formulation (final) has announced "Octaplas" human pooled plasma, solvent detergent treatment of the company, and was approved by the U.S. Food and Drug Administration (FDA). Supplementation and plasma coagulation factors in patients with liver disease, such as patients and surgery, such as plasma exchange transfusion or thrombotic thrombocytopenic purpura in patients with (TTP) is indicated. Solvent-detergent treatment to inactivate the virus effect is known, Octaplas to prevent allergic reactions and non-hemolytic transfusion-related acute lung injury.